Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
China flag China · Delayed Price · Currency is CNY
36.04
-0.39 (-1.07%)
Aug 31, 2026, 3:00 PM CST

SHA:600329 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
848.152,1312,229986.71861.79769.14
Depreciation & Amortization
108.3111.32125.94130.13116.56115.53
Other Amortization
18.513.722.273.034.112.26
Loss (Gain) From Sale of Assets
-2.58-2.83-0.11-0.15-1.08-12.32
Asset Writedown & Restructuring Costs
117.71117.71113.844.3620.161.93
Loss (Gain) From Sale of Investments
-87.26-1,646-1,908-308.11-274.22-213.49
Provision & Write-off of Bad Debts
4.887.4144.7819.099.224.89
Other Operating Activities
52.8916.5939.3938.9254.0232.68
Change in Accounts Receivable
308.14-260.4226.2574.01-732.29-42.07
Change in Inventory
37.51117.7321.95-165.3458.87-47.4
Change in Accounts Payable
-577.54-113.1288.5-56.06609.67220.2
Change in Other Net Operating Assets
---0.02-18.986.8210.15
Operating Cash Flow
805.41461.07924.67688.49677.25852.4
Operating Cash Flow Growth
-6.04%-50.14%34.30%1.66%-20.55%26.96%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-112.21-118.61-117.81-140.93-107.9-156.95
Sale of Property, Plant & Equipment
0.460.390.080.191.4928.71
Cash Acquisitions
-----47.61-
Divestitures
---347.8---
Investment in Securities
645.41-1,310805.42-606.35-65.08-334.92
Other Investing Activities
342.1720.662.42178.18206.82151.3
Investing Cash Flow
875.83-1,408342.31-568.91-12.28-311.85

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-51,221870.86205.65-
Total Debt Issued
551,221870.86205.65-
Long-Term Debt Repaid
--4.6-522.3-807.34-39.87-1.42
Total Debt Repaid
-6.28-4.6-522.3-807.34-39.87-1.42
Net Debt Issued (Repaid)
-1.280.4698.7763.52165.78-1.42
Repurchase of Common Stock
---0.28-22.67--1.35
Common Dividends Paid
-2,859-981.29-1,011-877.33-387.43-232.06
Other Financing Activities
---7.792.7-14.96-9.87
Financing Cash Flow
-2,860-980.88-319.89-833.77-236.62-244.7

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.91-0.22-0.040.050.01-
Net Cash Flow
-1,179-1,928947.05-714.15428.35295.85

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
693.2342.45806.86547.56569.34695.45
Free Cash Flow Growth
-5.67%-57.56%47.36%-3.83%-18.13%44.21%
Free Cash Flow Margin
14.68%6.96%11.04%6.66%6.90%10.07%
Free Cash Flow Per Share
0.900.451.050.710.730.90
Levered Free Cash Flow
1,4732,0661,818360.35961.19149.46
Unlevered Free Cash Flow
1,4792,0721,843382.76967.61151.29

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
1,2751,210751.63765.94526.93496.73
Change in Working Capital
-255.18-288.14277.05-225.49-113.32151.76